Safety and Pharmacokinetics of Single-Dose Novel Oral Androgen 11β-Methyl-19-Nortestosterone-17β-Dodecylcarbonate in Men-Reference-Cited by-同舟云学术

Safety and Pharmacokinetics of Single-Dose Novel Oral Androgen 11β-Methyl-19-Nortestosterone-17β-Dodecylcarbonate in Men

Published:2018-09-24 Issue:3 Volume:104 Page:629-638
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Wu Sherry¹,Yuen Fiona²,Swerdloff Ronald S²^ORCID,Pak Youngju²,Thirumalai Arthi¹,Liu Peter Y²^ORCID,Amory John K¹,Bai Feng²,Hull Laura²,Blithe Diana L³,Anawalt Bradley D¹,Parman Toufan⁴,Kim Kyuri⁴,Lee Min S³,Bremner William J¹,Page Stephanie T¹,Wang Christina²^ORCID

Affiliation:

1. Department of Medicine, University of Washington, Seattle, Washington

2. Department of Medicine, Division of Endocrinology, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California

3. Contraception Development Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland

4. SRI International Biosciences Division, Menlo Park, California

Funder

Eunice Kennedy Shriver National Institute of Child Health and Human Development

National Center for Advancing Translational Sciences

National Institute of Diabetes and Digestive and Kidney Diseases

National Heart, Lung, and Blood Institute

Publisher

The Endocrine Society

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/104/3/629/27506652/jc.2018-01528.pdf